P
PhylloPharma
Inactive2/10Traction
phyllopharmallc.com
Website failed a live check on Oct 21, 2026; recheck pending
The startup develops a platform for the oral delivery of therapeutic proteins, specifically focusing on insulin produced in the chloroplasts of genetically modified lettuce. This technology provides a plant-based method for patients to access insulin, addressing the challenges of traditional injection methods and improving patient compliance.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a platform for the oral delivery of therapeutic proteins, specifically focusing on insulin produced in the chloroplasts of genetically modified lettuce. This technology provides a plant-based method for patients to access insulin, addressing the challenges of traditional injection methods and improving patient compliance.